Aerosol chemo spray shows promise for Hard-to-Treat ovarian cancer
NCT ID NCT04811703
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for women with advanced ovarian, fallopian tube, or peritoneal cancer whose tumors did not shrink enough with standard chemotherapy. Researchers are testing a new method called PIPAC, which delivers chemotherapy as a pressurized spray directly into the abdomen, combined with standard IV chemo. The goal is to find the safest dose and see if this combination can make tumors removable by surgery. About 15 women will take part in this early-stage safety trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL CARCINOMA OF THE FALLOPIAN TUBES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Claude Huriez - Chirurgie générale et digestive
RECRUITINGLille, France
Contact Email: •••••@•••••
Contact
-
Hôpital Claude Huriez - Oncologie médicale
RECRUITINGLille, France
Contact Email: •••••@•••••
Contact
-
Hôpital Lyon Sud - Chirurgie Digestive et Oncologique
RECRUITINGPierre-Bénite, 69495, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Lyon Sud - Chirurgie Gynécologique et oncologique-obstétrique
RECRUITINGPierre-Bénite, France
Contact Email: •••••@•••••
Contact
-
Hôpital Lyon Sud - Oncologie Médicale
RECRUITINGPierre-Bénite, France
Contact
Contact Email: •••••@•••••
-
Hôpital de la Croix-Rousse
RECRUITINGLyon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Triple chemo cocktail aims to clear deadly bowel blockages in advanced stomach cancer
- Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
- New drug combo aims to tackle Chemotherapy-Resistant colorectal cancer in the abdomen
- Light-Activated therapy shows promise for tumor control without surgery
- Engineered immune cells take aim at Hard-to-Treat cancers
- Cancer-Fighting virus shows promise in Hard-to-Treat ovarian cancer